Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.

Clinical trial NCT07120217 · COMPLETED

Trial details

NCT number: NCT07120217
Sponsor: Federico II University
Status: COMPLETED
Study type: OBSERVATIONAL

Hodgkin Disease Breast Cancer Liposomal Doxorubicin

Start date: 2008-01-01
Primary completion: 2025-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.